Retatrutide — Bulk Raw Material
99.4% HPLC PurityResearch-grade Retatrutide raw material, priced per gram for bulk orders. $200/gram — choose the number of grams. 99.4% HPLC purity, COA verified.

SKU: PW-001 • Batch: PW-260301
Research-grade Retatrutide 10mg lyophilised powder. 99.4% HPLC purity, COA verified. Triple GLP-1/GIP/Glucagon receptor agonist for metabolic research.
Read the full description ↓✓Free shipping on orders over $750 AUD
✓Tracked international post — Standard $39.99 / Express $69.99 AUD
✓Dispatched next business day (orders before 11PM AEST)
Research-grade Retatrutide raw material, priced per gram for bulk orders. $200/gram — choose the number of grams. 99.4% HPLC purity, COA verified.
Purity independently verified by an accredited third-party laboratory via HPLC & mass spectrometry.
Retatrutide (LY3437943) is a novel triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Supplied as a lyophilised powder at 99.4% HPLC purity with full Certificate of Analysis (COA) documentation.
Our Retatrutide is sourced exclusively from GMP-certified manufacturing facilities with full chain-of-custody documentation maintained from synthesis to our Australian labs. Every batch undergoes independent third-party HPLC testing, mass spectrometry identity confirmation, LAL endotoxin assay (<1.0 EU/mg), and sterility screening before dispatch.
Research has explored Retatrutide's simultaneous activation of three complementary receptor pathways for effects on energy homeostasis, body composition, and metabolic function, producing distinct profiles compared to single (GLP-1) or dual (GLP-1/GIP) agonists studied in the literature.
Also searched as: Reta peptide, R3ta, Reda peptide, Ratatouille peptide
Retatrutide turns up online under a handful of alternate spellings. Researchers usually shorten it to Reta peptide, or simply Reta, and the numeric form R3ta peptide circulates in research communities. Reda peptide and Ratatouille peptide are two autocorrect misspellings that surface often enough to be worth naming. Each of these refers to the same triple agonist research compound: Retatrutide (LY3437943), the product on this page.
Retatrutide (LY3437943) is a triple GLP-1/GIP/Glucagon receptor agonist investigated in preclinical and clinical research for its effects on metabolic function, body weight regulation, and energy homeostasis. All use is strictly for in-vitro laboratory research only.
Our Retatrutide 10mg is independently verified at 99.4% HPLC purity. Each batch is tested by an accredited third-party laboratory and comes with a full Certificate of Analysis (COA).
Lyophilised Retatrutide should be stored at −20°C for long-term stability. Once reconstituted with bacteriostatic water, store at 2–8°C and use within 4 weeks. Avoid repeated freeze-thaw cycles.
Add bacteriostatic water (BAC water) slowly to the vial at a 1–2mL volume. Gently swirl; do not shake. Allow the lyophilised powder to dissolve completely before use in research protocols.
Current batch: PW-260301. The COA for this batch is available on our COA Library page, including full HPLC chromatogram, purity %, mass spectrometry data, and endotoxin results.
Yes. Every batch of Retatrutide ships with a downloadable COA including HPLC purity percentage, mass spectrometry identity confirmation, sterility results, and LAL endotoxin assay data.
Semaglutide is a single GLP-1 receptor agonist, while Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. In research settings, Retatrutide's multi-receptor activity produces distinct metabolic effects compared to single-target compounds.
Due to high demand, Retatrutide is currently available on pre-order with dispatch within 7–10 days of payment. Use code PREORDER at checkout for 10% off your first order.
Bacteriostatic water (BAC water) is the recommended reconstitution solvent for Retatrutide. We stock pharmaceutical-grade BAC water 10mL in our Supplies category.
Retatrutide 10mg is sold strictly for in-vitro laboratory and research purposes only. This product is not intended for human consumption, therapeutic use, cosmetic use, or veterinary application. You must be 18 years of age or older to purchase. By purchasing, you confirm that you are a qualified researcher and will use this product in compliance with all applicable laws and regulations.
No questions yet — be the first to ask about this product.
Research-grade Tirzepatide 10mg lyophilised powder. 99.5% HPLC purity, COA verified. Dual GIP/GLP-1 receptor agonist for metabolic research.
Research-grade BPC-157 (Body Protection Compound) 10mg lyophilised powder. 99.2% HPLC purity, COA verified. Stable pentadecapeptide for tissue healing and gut research.
Recent peer-reviewed studies from PubMed related to Retatrutide. Provided for research context — not medical advice.
Retatrutide-A Game Changer in Obesity Pharmacotherapy
Katsi V, Koutsopoulos G, Fragoulis C, et al. · Biomolecules · 2025
PMID: 40563436
Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial
Jastreboff AM, Kaplan LM, Frías JP, et al. · The New England journal of medicine · 2023
PMID: 37366315
The power of three: Retatrutide's role in modern obesity and diabetes therapy
Abdul-Rahman T, Roy P, Ahmed FK, et al. · European journal of pharmacology · 2024
PMID: 39515565
Retatrutide for the treatment of obesity, obstructive sleep apnea and knee osteoarthritis: Rationale and design of the TRIUMPH registrational clinical trials
Giblin K, Kaplan LM, Somers VK, et al. · Diabetes, obesity & metabolism · 2026
PMID: 41090431
Source: U.S. National Library of Medicine (PubMed). Citations are fetched live and cached; inclusion does not imply endorsement of any therapeutic use.